Circulating IgE levels in patients with gynecological tumors.
Serum IgE levels in 148 women with a histological confirmed genital cancer of different stage and site and from 23 patients with benign ovarian tumors were determined prior to therapy. For determination of IgE an enzyme-linked immunosorbent assay was used. Result obtained did not give evidence that circulating IgE levels are different to healthy control subjects. Findings were not influenced by tumor-localization, by primary tumor or recurrence.
D000368:Aged; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005833:Genital Neoplasms, Female / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis*; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D007073:Immunoglobulin E